NCT06899061 2026-03-03
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
AstraZeneca
Phase 1 Active not recruiting
AstraZeneca
M.D. Anderson Cancer Center
Biocity Biopharmaceutics Co., Ltd.